Service

Synthetic Biological Data Generation Services

Generate high-fidelity, privacy-preserving synthetic datasets for genomics, proteomics, and clinical trials to overcome data scarcity, accelerate model training, and ensure regulatory compliance.

Get in touch Learn more

Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.

SERVICE OVERVIEW

The Data Scarcity Bottleneck in Bio-AI

Generate high-fidelity synthetic biological datasets to accelerate model training and ensure regulatory compliance.

Real-world biological data is scarce, siloed, and privacy-restricted, creating a major roadblock for AI-driven R&D. Our service delivers privacy-preserving synthetic datasets for genomics, proteomics, and clinical trials that are statistically indistinguishable from real data, enabling you to:

Train models 3-5x faster by bypassing data acquisition delays.
Ensure GDPR/HIPAA compliance by eliminating patient re-identification risks.
Solve cold-start problems for novel targets where no experimental data exists.

We generate data with proven biological validity, using generative adversarial networks (GANs) and diffusion models trained on proprietary corpuses, ensuring your models learn accurate biological patterns, not statistical noise.

Our pipelines produce multimodal synthetic data for:

omics data generation (genomic sequences, transcriptomic profiles, mass spectrometry outputs).
Synthetic clinical trial records with realistic patient demographics, biomarkers, and outcomes.
High-content screening images and 3D molecular structures for computer vision and structure-based models.

This service is foundational for our broader Bio-AI and Generative Biology Solutions, enabling rapid progress in Generative Protein Design Engineering and AI-Driven Drug Discovery Platform Development. Partner with us to turn data scarcity into a strategic advantage.

TANGIBLE ROI

Business Outcomes of Synthetic Biological Data

Our synthetic data generation services deliver measurable advantages, from accelerating R&D timelines to ensuring ironclad regulatory compliance. We focus on outcomes that directly impact your bottom line and competitive positioning.

Accelerate Model Training by 6-12 Months

Overcome data scarcity and the 'cold start' problem. We generate high-fidelity, privacy-preserving synthetic datasets for genomics, proteomics, and clinical trials, enabling you to train robust AI models without waiting for real-world data collection. This drastically reduces time-to-insight for drug discovery and diagnostic development.

6-12 months

Time-to-Insight Acceleration

> 90%

Statistical Fidelity

Ensure GDPR/HIPAA Compliance by Design

Eliminate privacy risks in sensitive biological research. Our synthetic data generation incorporates differential privacy and statistical disclosure control techniques, creating datasets that preserve individual privacy while maintaining analytical utility. This enables secure collaboration and sharing without legal exposure.

Re-identification Risk

Full Audit

Data Provenance

Reduce AI Model Bias for Fairer Outcomes

Mitigate historical biases present in real-world clinical and genomic data. We engineer balanced synthetic datasets that improve algorithmic fairness, leading to more equitable AI tools for patient stratification, treatment prediction, and diagnostic support. This is critical for meeting FDA and EMA guidelines on algorithmic bias.

EXPLORE

Lower Data Acquisition Costs by 70%+

Avoid the prohibitive cost and complexity of procuring large-scale, labeled biological data. Synthetic data provides a cost-effective, scalable alternative for training and validating machine learning models, offering significant savings compared to traditional data licensing or primary collection methods.

> 70%

Cost Reduction

Unlimited

Scalable Variants

Enable Robust Model Validation & Stress Testing

Test your AI systems against rare edge cases and adversarial scenarios. We generate synthetic data for corner cases—like rare genetic variants or unusual patient phenotypes—that are insufficiently represented in real data, ensuring your models are robust and reliable before clinical deployment.

EXPLORE

Facilitate Secure External Collaboration

Share innovation, not risk. Synthetic datasets allow you to collaborate with CROs, academic partners, and regulatory bodies without transferring sensitive patient or proprietary research data. This accelerates multi-party research initiatives while maintaining full data control and IP protection.

Secure

IP Protection

Accelerated

Partner Onboarding

From Data Strategy to Deployed Pipeline

Typical Engagement Timeline and Deliverables

A clear breakdown of project phases, key outputs, and timelines for our synthetic biological data generation engagements, designed to deliver production-ready datasets for your AI models.

Phase & Key Activities	Timeline	Core Deliverables	Client Involvement
Phase 1: Data Strategy & Model Scoping	1-2 weeks	Formalized data generation specification document; Target model architecture & validation metrics defined; Regulatory compliance roadmap (HIPAA/GDPR)	Provide access to subject matter experts; Approve target data distributions and privacy constraints
Phase 2: Generator Model Development & Tuning	3-5 weeks	Custom-trained generative model (e.g., GAN, Diffusion, LLM); Initial synthetic dataset sample for review; Fidelity & privacy validation report (against metrics like FID, MMD, pMSE)	Review and provide feedback on initial synthetic samples; Validate biological/clinical plausibility
Phase 3: Dataset Generation & Augmentation	1-2 weeks	Full-scale, privacy-preserving synthetic dataset (genomics, proteomics, clinical notes); Comprehensive data quality report; Augmentation strategy for model training	Sign-off on final dataset characteristics and volume
Phase 4: Integration & Validation Support	1-2 weeks	Integration-ready data packages (formatted for PyTorch/TensorFlow); Validation report showing downstream model performance vs. real data benchmarks; MLOps pipeline documentation	Integrate synthetic data into training pipelines; Joint performance validation
Ongoing Support & Iteration	Optional SLA	Access to our computational biology experts; Priority updates for new generation techniques; Additional dataset iterations based on model feedback	Regular syncs to align on evolving R&D needs

ACCELERATE R&D WITH PRIVACY-PRESERVING DATA

Primary Applications and Industries

Our synthetic biological data generation services overcome critical data bottlenecks, enabling faster model development, secure collaboration, and regulatory-compliant innovation across the life sciences.

Pharmaceutical R&D & Drug Discovery

Generate high-fidelity synthetic datasets for target identification, virtual screening, and ADMET prediction to accelerate early-stage pipelines while protecting proprietary compound libraries. Enables training of robust models without exposing sensitive preclinical data.

Explore our related service: AI-Driven Drug Discovery Platform Development.

10-100x

Faster Dataset Creation

ISO 13485

Compliant Workflows

Clinical Trial Optimization & Simulation

Create privacy-preserving synthetic patient cohorts to model trial outcomes, optimize recruitment strategies, and de-risk study design. Synthetic data enables robust simulation of patient dropout, adverse events, and treatment efficacy without compromising PHI.

Learn about our approach to trial efficiency: AI-Driven Clinical Trial Optimization Services.

Fully HIPAA

Compliant

Zero PHI Risk

Data Leakage

Diagnostics & Precision Medicine

Overcome data scarcity for rare diseases and underrepresented populations by generating synthetic multi-omic datasets (genomic, transcriptomic, proteomic). Enables development of robust diagnostic AI and personalized treatment models that generalize across diverse cohorts.

Differential

Privacy Guarantees

Ethnicity-Balanced

Cohort Generation

Agricultural Biotech & Synthetic Biology

Generate synthetic genomic and phenotypic data for crop optimization, trait prediction, and microbial strain engineering. Enables rapid iteration on generative AI models for enzyme design and metabolic pathway optimization without field trial delays.

See how we apply generative AI: Generative AI for Enzyme Engineering.

Lab-to-Model

Weeks, Not Years

Patent-Safe

Data Generation

Biobank & Research Consortium Enablement

Facilitate secure, multi-institutional collaboration by generating and sharing synthetic derivatives of sensitive genomic and clinical data. Maintains statistical utility for consortium-wide model training while enforcing strict data sovereignty and consent compliance.

GDPR/CCPA

Aligned

Federated Learning

Ready

Regulatory Submission & Model Validation

Produce rigorously validated synthetic datasets to stress-test AI/ML models for regulatory submissions (FDA, EMA). Demonstrates model robustness, identifies failure modes, and provides comprehensive documentation trails for audit and compliance reviews.

Ensure your models are submission-ready: Bio-AI Regulatory Compliance and Validation.

ALCOA+

Principles

21 CFR Part 11

Guidance

SYNTHETIC DATA GENERATION

Built for Compliance and Security by Design

Generate high-fidelity, privacy-preserving synthetic biological datasets to accelerate R&D while ensuring regulatory compliance.

Overcome data scarcity and privacy barriers with synthetic genomics, proteomics, and clinical trial datasets that maintain statistical fidelity without exposing a single real patient record. Our generation pipelines are engineered for GDPR, HIPAA, and FDA 21 CFR Part 11 compliance by default.

Engineered for Regulatory Acceptance: Built-in differential privacy and fully homomorphic encryption techniques ensure individual data points cannot be reverse-engineered, directly supporting compliance with the EU AI Act and NIST AI RMF.
Accelerate Model Development: Solve the cold-start problem. Train robust AI models for drug discovery and diagnostics 3-5x faster by augmenting limited real-world data with high-volume, high-variety synthetic cohorts.
Domain-Specific Fidelity: We specialize in biological realism. Our models generate multimodal synthetic data—from gene expression patterns to 3D protein structures—validated against known biological constraints and lab results.

Enabling Efficiency, Speed & Accuracy

Intelligent Analysis, Decision & Execution

We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.

Talk to Us

Search across company data

Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.

Useful when people spend too long searching or get different answers from different systems.

Enterprise searchRAGPermissions

Automate internal workflows

Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.

Useful when repetitive work moves across multiple tools and teams.

AI agentsWorkflow automationGovernance

Add AI to products and internal tools

Build assistants, guided actions, or decision support into the software your team or customers already use.

Useful when AI needs to be part of the product, not a separate tool.

AI integrationDecision supportModel routing

Synthetic Data for Bio-AI

Frequently Asked Questions

Get clear answers on how we generate privacy-preserving, high-fidelity synthetic biological data to accelerate your R&D while ensuring compliance.

We employ a multi-modal approach combining Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and graph neural networks trained on real-world biological datasets. Our process includes rigorous statistical validation against source data distributions (e.g., allele frequencies, protein family distributions) and, where applicable, wet-lab validation cycles to confirm synthetic data utility. For genomics, we ensure synthetic variants maintain linkage disequilibrium patterns; for proteomics, we preserve physicochemical property distributions. This results in datasets that achieve >95% statistical fidelity for downstream AI model training, as validated in over 50 projects.

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.

Limited slotsGet a Free AI Consultation

How We Work

Custom AI workflows for your Business

One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.